已收盘 12-12 16:00:00 美东时间
+1.650
+1.13%
今日重点评级关注:Ascendiant Capital:维持Lucid Diagnostics"买入"评级,目标价从8美元升至8.25美元;Ascendiant Capital:维持Aytu BioPharma"买入"评级,目标价从12.5美元升至13美元
12-11 10:33
U.S. stocks were mixed, with the Nasdaq Composite falling more than 100 points ...
12-10 23:41
今日重点评级关注:Stifel:维持X4 Pharmaceuticals"买入"评级,目标价从7.5美元升至10美元;花旗:维持UP Fintech Holding"买入"评级,目标价从17.4美元升至17.5美元
12-08 08:34
Canaccord Genuity analyst Brian McNamara maintains Middleby (NASDAQ:MIDD) with a Buy and raises the price target from $171 to $175.
12-06 03:13
ITT Inc. (NYSE: ITT) to acquire SPX FLOW from Lone Star Funds for $4.775 billion. Deal expected to boost IP segment.
12-05 20:21
Middleby Corp (MIDD) sells 51% stake in Residential Kitchen business to 26North Partners LP for $540M+ upfront cash, plus $135M seller note.
12-04 21:18
The Middleby Corporation ("Middleby") (NASDAQ:MIDD) today announced entry into a definitive agreement under which it will sell a 51% stake in its Residential Kitchen business to affiliates of 26North Partners LP
12-04 19:33
Shares of companies in the broader machinery sector are trading higher. Stocks ...
11-22 04:53
今日重点评级关注:Piper Sandler:维持MeiraGTx Hldgs"超配"评级,目标价从28美元升至30美元;RBC Capital:维持4D Molecular Therapeutics"跑赢大市"评级,目标价从26美元升至32美元
11-12 11:43
今日重点评级关注:HC Wainwright & Co.:维持Adicet Bio"买入"评级,目标价从4美元升至9美元;Citizens: 维持Rapport Therapeutics"跑赢大市"评级,目标价从77美元升至80美元
11-10 17:17